JOSEPH HUDSON: Open Payments
NPI 1881848695 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,411 in 59 payments from 17 companies in 2025. Trend: 2023 $1,411 · 2024 $2,130 · 2025 $1,411
Food & beverage: $1,411
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 8 | $166 |
| PFIZER INC. | 4 | $134 |
| Incyte Corporation | 5 | $131 |
| Amgen Inc. | 5 | $117 |
| Galderma Laboratories, L.P. | 5 | $109 |
| Arcutis Biotherapeutics, Inc. | 4 | $93 |
| Novartis Pharmaceuticals Corporation | 4 | $93 |
| ABBVIE INC. | 4 | $92 |
| Lilly USA, LLC | 4 | $91 |
| Janssen Biotech, Inc. | 3 | $90 |
Products named: Bimzelx, CIBINQO, OPZELURA, OTEZLA, Zoryve, TALTZ, TREMFYA, DAXXIFY.
Industry payments across DC — which companies pay providers there.
